148 related articles for article (PubMed ID: 26630529)
1. Survival in familial and non-familial breast cancer by age and stage at diagnosis.
Kharazmi E; Försti A; Sundquist K; Hemminki K
Eur J Cancer; 2016 Jan; 52():10-8. PubMed ID: 26630529
[TBL] [Abstract][Full Text] [Related]
2. Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study.
Kharazmi E; Chen T; Narod S; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2014 Feb; 144(1):185-92. PubMed ID: 24487690
[TBL] [Abstract][Full Text] [Related]
3. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
4. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C; Czene K
Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
[TBL] [Abstract][Full Text] [Related]
5. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
[TBL] [Abstract][Full Text] [Related]
6. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
7. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
[TBL] [Abstract][Full Text] [Related]
8. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
9. Does family history influence survival in breast cancer cases?
Russo A; Herd-Smith A; Gestri D; Bianchi S; Vezzosi V; Rosselli Del Turco M; Cardona G
Int J Cancer; 2002 May; 99(3):427-30. PubMed ID: 11992413
[TBL] [Abstract][Full Text] [Related]
10. Risk of breast cancer in families of multiple affected women and men.
Bevier M; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
[TBL] [Abstract][Full Text] [Related]
11. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients.
Tilanus-Linthorst MM; Bartels KC; Alves C; Bakri B; Crepin E; van den Ouweland A; Klijn JG; Meijers-Heijboer H; Brekelmans CT
Breast Cancer Res Treat; 2006 Jan; 95(2):117-23. PubMed ID: 16319990
[TBL] [Abstract][Full Text] [Related]
12. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
Zheng G; Sundquist J; Sundquist K; Ji J
BMC Cancer; 2021 Nov; 21(1):1210. PubMed ID: 34772394
[TBL] [Abstract][Full Text] [Related]
13. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.
Baburin A; Aareleid T; Padrik P; Valvere V; Innos K
Acta Oncol; 2014 Feb; 53(2):226-34. PubMed ID: 23767956
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
Domchek SM; Gaudet MM; Stopfer JE; Fleischaut MH; Powers J; Kauff N; Offit K; Nathanson KL; Robson M
Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
[TBL] [Abstract][Full Text] [Related]
15. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
18. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer detection method among 20- to 49-year-old patients at a community based cancer center: 1990-2008.
Malmgren J; Atwood M; Kaplan H
Breast J; 2012; 18(3):257-60. PubMed ID: 22487162
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences in breast cancer risk and survival: a study on immigrants in Sweden.
Mousavi SM; Försti A; Sundquist J; Hemminki K
Acta Oncol; 2013 Nov; 52(8):1637-42. PubMed ID: 23317144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
